Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2000
11/16/2000CA2384338A1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373851A1 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373617A1 Compositions and methods for improving learning and memory
11/16/2000CA2373121A1 Vector-mediated delivery of integrating transposon sequences
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372807A1 Constitutive chimeric receptors, and methods of use thereof
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2371095A1 Enhanced delivery of nucleic acid-based drugs
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/15/2000EP1052288A1 Complex for transferring an anionic substance of interest into a cell
11/15/2000EP1052287A2 Complex for transferring an anionic substance of interest into a cell
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051495A2 Recombinant mistletoe lectines
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/14/2000US6147200 2'-O-acetamido modified monomers and oligomers
11/14/2000US6147194 Purified monoclonal antibody which binds inosine 5'-monophosphate dehydrogenase polypeptide which is encoded by a defined nucleotide sequence; immunoassays for detection
11/14/2000US6147056 Therapy for psoriasis
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
11/14/2000US6146886 RNA polymerase III-based expression of therapeutic RNAs
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146642 Recombinant new castle disease virus RNA expression systems and vaccines
11/14/2000US6146623 A gene therapy for treating cancer
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066778A1 Pituitrone gene and polypeptides
11/09/2000WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000WO2000066752A2 Gene construct for prodrug activation encoding a heterologous, glycosylphophati dylinositol-modified carboypeptidase g2 and a cell surface targettng signal peptide
11/09/2000WO2000066741A2 Conserved neisserial antigens
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066727A1 Tumour-associated antigen
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066720A2 The use of adeno-associated virus (aav) deliver cytoprotective genes
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066716A2 Method for producing organisms exhibiting increased sterol glycoside production and use of the sterol glycosides
11/09/2000WO2000066715A1 Method for diminishing specific immune reactions
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066628A1 Neurite outgrowth and guidance by tenascin-c
11/09/2000WO2000066619A2 Means and methods for altering the functional properties in eukaryotic cells
11/09/2000WO2000066609A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
11/09/2000WO2000066608A1 Tumor necrosis factor-gamma
11/09/2000WO2000066604A2 L-ribo-lna analogues
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066179A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066177A1 GENE THERAPY USING TGF-$g(b)
11/09/2000WO2000066176A2 Agent for gene therapy and for the prevention of metastases, as well as for the gene therapy of tumors
11/09/2000WO2000066162A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/09/2000WO2000035421A3 Integrative protein-dna cochleate formulations and methods for transforming cells
11/09/2000WO2000034497A3 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
11/09/2000WO2000034455A3 Methods and systems useful for transferring genes into pancreatic islets ex vivo and into the pancreas in vivo
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000031238A3 Methods and reagents for increasing proliferative capacity and preventing replicative senescence
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000029428A3 5t4 tumour-associated antigen for use in tumour immunotherapy
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000026367A3 Therapeutics and diagnostics for ocular abnormalities
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000024254A9 Compositions and methods for modulating expression within smooth muscle cells
11/09/2000WO2000015826A3 Leptin induced genes
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO1999047678A9 Interferon alpha plasmids and delivery systems, and methods of making and using the same
11/09/2000CA2373225A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
11/09/2000CA2373045A1 Gene therapy using tgf-.beta.
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372559A1 Neurite outgrowth and guidance by tenascin-c
11/09/2000CA2372235A1 Conserved neisserial antigens
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2371946A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
1 ... 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 ... 870